Skip to main content

Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Table 1 Five-year cumulative incidences of death among patients with melanoma

From: Melanoma-specific mortality and competing mortality in patients with non-metastatic malignant melanoma: a population-based analysis

    Cause-specific death Death from other causes
Characteristics N (%) Event 5-year (%) P 5-year (%) P
Total 40043 7216 7.1 (6.8 to 7.3)   7.4 (7.1 to 7.6)  
Age (years)     < 0.001   < 0.001
 20–39 years 5940 (14.8) 262 3.3 (2.8 to 3.7)   0.4 (0.3 to 0.6)  
 40–64 years 20766 (51.9) 2069 5.7 (5.4 to 6.0)   2.3 (2.1 to 2.5)  
 65+ years 13337 (33.3) 4885 10.8 (10.3 to 11.3)   18.2 (17.5 to 18.9)  
Sex     < 0.001   < 0.001
 Male 22295 (55.7) 4901 8.7 (8.3 to 9.1)   8.9 (8.5 to 9.3)  
 Female 17748 (44.3) 2315 5.0 (4.7 to 5.3)   5.4 (5.1 to 5.8)  
Race     < 0.001   0.006
 White 39559 (98.8) 7075 6.9 (6.6 to 7.1)   7.4 (7.1 to 7.7)  
 Non-white 484 (1.2) 141 20.7 (17.2 to 24.4)   4.2 (2.7 to 6.3)  
Melanoma subtype     < 0.001   < 0.001
 Superficial spreading melanoma 13444 (33.6) 1645 3.9 (3.6 to 4.2)   5.4 (5.0 to 5.8)  
 Nodular melanoma 2875 (7.2) 1233 25.6 (24.0 to 27.2)   12.1 (10.9 to 13.3)  
 Lentigo maligna melanoma 2383 (6.0) 547 3.4 (2.7 to 4.2)   14.5 (13.1 to 16.0)  
 Melanoma, NOS 18926 (47.3) 3131 6.2 (5.9 to 6.5)   6.9 (6.5 to 7.3)  
 Others 2415 (6.0) 660 12.8 (11.5 to 14.2)   9.2 (8.1 to 10.4)  
Anatomic sites     < 0.001   <0.001
 Extremities 18427 (46.0) 2811 5.9 (5.6 to 6.3)   6.2 (5.9 to 6.6)  
 Trunk 13987 (34.9) 2250 6.9 (6.5 to 7.3)   5.9 (5.5 to 6.3)  
 Face and ears 4819 (12.0) 1331 8.0 (7.2 to 8.8)   13.8 (12.8 to 14.8)  
 Scalp and neck 2810 (7.0) 824 13.9 (12.6 to 15.2)   10.8 (9.6 to 11.9)  
Thickness (mm)     < 0.001   < 0.001
  ≤ 1.00 28017 (70.0) 3086 2.2 (2.0 to 2.4)   5.9 (5.7 to 6.3)  
 1.01–2.00 6279 (15.7) 1415 9.4 (8.7 to 10.2)   8.1 (7.5 to 8.8)  
 2.01–4.00 3464 (8.9) 1391 21.2 (19.9 to 22.6)   11.8 (10.8 to 12.9)  
  > 4.00 2283 (5.7) 1324 38.1 (36.1 to 40.1)   15.2 (13.7 to 16.7)  
Ulceration     < 0.001   < 0.001
 Absent 35065 (87.6) 4916 4.1 (3.9 to 4.3)   6.6 (6.3 to 6.8)  
 Present 4978 (12.4) 2300 27.6 (26.4 to 28.9)   12.8 (11.9 to 13.8)  
Lymph node status     < 0.001   < 0.001
 N0 37363 (93.3) 5889 4.8 (4.6 to 5.0)   7.4 (7.1 to 7.7)  
 N1 1543 (3.9) 650 31.0 (28.7 to 33.4)   6.0 (4.9 to 7.3)  
 N2 762 (1.9) 401 38.8 (35.5 to 42.3)   7.8 (6.0 to 9.9)  
 N3 375 (0.9) 276 63.8 (58.7 to 68.5)   6.2 (4.0 to 8.9)  
Stage     <0.001   < 0.001
 I/II 37363 (93.3) 5889 4.8 (4.6 to 5.0)   7.4 (7.1 to 7.7)  
 III 2680 (6.7) 1327 37.8 (36.0–39.7)   6.5 (5.7–7.5)  
  1. Abbreviation: NOS malignant melanoma, not otherwise specified